Home » UK Cost Agency Rejects Drugs From AstraZeneca, Bristol and Roche
UK Cost Agency Rejects Drugs From AstraZeneca, Bristol and Roche
Britain’s healthcare cost watchdog NICE said on Friday it was not able to recommend a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, and has asked for more information from the companies.
Reuters
Reuters
Upcoming Events
-
07May
-
14May
-
30May